Works matching IS 02692813 AND DT 2022 AND VI 55 AND IP 6
Results: 25
Cover Image.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. i, doi. 10.1111/apt.16881
- By:
- Publication type:
- Article
Editorial: infections and hepatic encephalopathy—does the chicken or the egg come first? A novel perspective at the horizon. Authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial: time to modify practice and use the modified Rutgeert's score.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial: a paradigm shift in NUDT15 assessment—towards predictive and personalised medicine in Crohn's disease? Authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Gut‐brain axis dysfunction underlies FODMAP‐induced symptom generation in irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. 670, doi. 10.1111/apt.16812
- By:
- Publication type:
- Article
Editorial: suboptimal ultrasound visualisation in patients undergoing surveillance for hepatocellular carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial: infections and hepatic encephalopathy–does the chicken or the egg come FIRST? A novel perspective at the horizon.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Systematic review: development of a consensus code set to identify cirrhosis in electronic health records.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. 645, doi. 10.1111/apt.16806
- By:
- Publication type:
- Article
Editorial: anti‐TNF combination therapy for inflammatory bowel disease–one size does not fit all.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Letter: the potential link between oesophageal hypervigilance, visceral anxiety, increased swallow rate and oesophageal mucosal integrity—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. 758, doi. 10.1111/apt.16801
- By:
- Publication type:
- Article
Editorial: a paradigm shift in NUDT15 assessment—towards predictive and personalised medicine in Crohn's disease?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial: protecting hypoxia‐inducible factor 1a and gut integrity with GB004—a promising therapeutic approach for ulcerative colitis? Authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial: MAFLD and outcome prediction—author's reply.
- Published in:
- 2022
- Publication type:
- Editorial
Overt hepatic encephalopathy is an independent risk factor for de novo infection in cirrhotic patients with acute decompensation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. 722, doi. 10.1111/apt.16790
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: incidence and factors for progression to advanced neoplasia in inflammatory bowel disease patients with indefinite and low‐grade dysplasia.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. 632, doi. 10.1111/apt.16789
- By:
- Publication type:
- Article
Letter: the potential link between oesophageal hypervigilance, visceral anxiety, increased swallow rate and oesophageal mucosal integrity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. 756, doi. 10.1111/apt.16783
- By:
- Publication type:
- Article
Review article: randomised controlled trials in inflammatory bowel disease—common challenges and potential solutions.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. 658, doi. 10.1111/apt.16781
- By:
- Publication type:
- Article
Editorial: therapeutic phlebotomy for iron overload—start with a diagnosis before bleeding.
- Published in:
- 2022
- Publication type:
- Editorial
Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. 683, doi. 10.1111/apt.16779
- By:
- Publication type:
- Article
Editorial: MAFLD and outcome prediction.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
NAFLD‐related gene polymorphisms and all‐cause and cause‐specific mortality in an Asian population: the Shanghai Changfeng Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. 705, doi. 10.1111/apt.16772
- By:
- Publication type:
- Article
Editorial: protecting hypoxia‐inducible factor‐1α and gut integrity with GB004—a promising therapeutic approach for ulcerative colitis?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. 700, doi. 10.1111/apt.16739
- By:
- Publication type:
- Article
A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. 691, doi. 10.1111/apt.16735
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. 629, doi. 10.1111/apt.16416
- Publication type:
- Article